Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma
Alessandra De Leo(Moffitt Cancer Center), Filippo Veglia(Moffitt Cancer Center), Paulo C. Rodrı́guez(Moffitt Cancer Center), Luca D’Angelo(Policlinico Umberto I), Antonio Santoro(Policlinico Umberto I), José R. Conejo-García(Duke University), Fabio Scirocchi(Bambino Gesù Children's Hospital), Marianna Nuti(National Institutes of Health), James K. Liu(Moffitt Cancer Center), Arnold B. Etame(Moffitt Cancer Center), Angelica Pace(Sapienza University of Rome), Aurelia Rughetti(Sapienza University of Rome), Xiaoqing Yu(Moffitt Cancer Center), Alessio Ugolini(The Wistar Institute), Delia Scocozza(Moffitt Cancer Center), Michael A. Vogelbaum(Moffitt Cancer Center), Bárbara Peixoto(Moffitt Cancer Center)
Cited by 252
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses
|Cancer Research|2004|1.2k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
|Cell|2015|921
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
|Journal of Clinical Oncology|2021|775